Follow
Rob van der Kant
Rob van der Kant
Postdoctoral Researcher KULeuven
Verified email at kuleuven.vib.be
Title
Cited by
Cited by
Year
Prediction and reduction of the aggregation of monoclonal antibodies
R van der Kant, AR Karow-Zwick, J Van Durme, M Blech, R Gallardo, ...
Journal of molecular biology 429 (8), 1244-1261, 2017
1452017
GPCRDB: an information system for G protein-coupled receptors
V Isberg, B Vroling, R van der Kant, K Li, G Vriend, D Gloriam
Nucleic acids research 42 (D1), D422-D425, 2014
1382014
Hsp90 mediates membrane deformation and exosome release
E Lauwers, YC Wang, R Gallardo, R Van der Kant, E Michiels, J Swerts, ...
Molecular cell 71 (5), 689-702. e9, 2018
1362018
Solubis: a webserver to reduce protein aggregation through mutation
J Van Durme, G De Baets, R Van Der Kant, M Ramakers, A Ganesan, ...
Protein Engineering, Design and Selection 29 (8), 285-289, 2016
662016
Post-translational control of the temporal dynamics of transcription factor activity regulates neurogenesis
XJ Quan, L Yuan, L Tiberi, A Claeys, N De Geest, J Yan, R Van Der Kant, ...
Cell 164 (3), 460-475, 2016
642016
Structural hot spots for the solubility of globular proteins
A Ganesan, A Siekierska, J Beerten, M Brams, J Van Durme, G De Baets, ...
Nature communications 7 (1), 10816, 2016
622016
Alpha-bulges in G protein-coupled receptors
R Van der Kant, G Vriend
International journal of molecular sciences 15 (5), 7841-7864, 2014
452014
Defective Sec61α1 underlies a novel cause of autosomal dominant severe congenital neutropenia
E Van Nieuwenhove, JS Barber, J Neumann, E Smeets, M Willemsen, ...
Journal of Allergy and Clinical Immunology 146 (5), 1180-1193, 2020
382020
Thermodynamic and evolutionary coupling between the native and amyloid state of globular proteins
T Langenberg, R Gallardo, R van der Kant, N Louros, E Michiels, ...
Cell reports 31 (2), 2020
362020
Reverse engineering synthetic antiviral amyloids
E Michiels, K Roose, R Gallardo, L Khodaparast, L Khodaparast, ...
Nature communications 11 (1), 2832, 2020
342020
Autonomous aggregation suppression by acidic residues explains why chaperones favour basic residues
B Houben, E Michiels, M Ramakers, K Konstantoulea, N Louros, ...
The EMBO journal 39 (11), e102864, 2020
322020
Thermodynamic analysis of amyloid fibril structures reveals a common framework for stability in amyloid polymorphs
R van der Kant, N Louros, J Schymkowitz, F Rousseau
Structure 30 (8), 1178-1189. e3, 2022
22*2022
Solubis: optimize your protein
G De Baets, J Van Durme, R van der Kant, J Schymkowitz, F Rousseau
Bioinformatics 31 (15), 2580-2582, 2015
222015
Adaption of human antibody λ and κ light chain architectures to CDR repertoires
R van der Kant, J Bauer, AR Karow-Zwick, S Kube, P Garidel, M Blech, ...
Protein Engineering, Design and Selection 32 (3), 109-127, 2019
152019
The effect of mutation on an aggregation-prone protein: An in vivo, in vitro, and in silico analysis
N Guthertz, R Van Der Kant, RM Martinez, Y Xu, CH Trinh, BI Iorga, ...
Proceedings of the National Academy of Sciences 119 (22), e2200468119, 2022
9*2022
StAmP-DB: a platform for structures of polymorphic amyloid fibril cores
N Louros, R Van Der Kant, J Schymkowitz, F Rousseau
Bioinformatics 38 (9), 2636-2638, 2022
92022
SolubiS: Optimizing protein solubility by minimal point mutations
R van der Kant, J van Durme, F Rousseau, J Schymkowitz
Protein Misfolding Diseases: Methods and Protocols, 317-333, 2019
92019
Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4V
F Claes, S Rudyak, AS Laird, N Louros, J Beerten, M Debulpaep, ...
Protein Engineering, Design and Selection 32 (10), 443-457, 2019
62019
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein
K Janssen, F Claes, D Van de Velde, VL Wehbi, B Houben, Y Lampi, ...
Proceedings of the National Academy of Sciences 120 (9), e2214921120, 2023
22023
A Novel Anti-L1CAM Antibody-Radionuclide-Conjugate (ARC) as New Treatment Option for Ovarian Cancer
C Geraths, M Behe, D Winkler, M Hackebeil, A Blanc, T Chiorazzo, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 50 (SUPPL 1), S63-S63, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20